Lack of association of the angiotensinogen-6 polymorphism with blood pressure levels in the comprehensive NHLBI Family Blood Pressure Program

Journal of Hypertension

Volumn 18, Issue 7, 2000, Pages 867-876

  Province, Michael A ^a   Boerwinkle, Eric ^b   Chakravarti, Aravinda ^c   Cooper, Richard ^d   Fornage, Myriam ^b   Leppert, Mark ^e   Risch, Neil ^f   Ranade, Koustubh ^f  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensinogen; Hypertension; Pre planned meta analysis; Proportional hazards

Indexed keywords

ANGIOTENSINOGEN; ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CAUCASIAN; CHINESE; CLINICAL PROTOCOL; DATA ANALYSIS; DIASTOLIC BLOOD PRESSURE; ETHNIC GROUP; FAMILY STUDY; FEMALE; GENETIC POLYMORPHISM; HUMAN; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; SIBLING; SYSTOLIC BLOOD PRESSURE;

EID: 0033941303     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200018070-00008     Document Type: Article

References (36)

1. 1 Jeunemaitre X, Soubrier F, Kotelevtsev Y, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71:169-180.
2. 2 Bnoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997; 99:1786-1797.
3. 3 Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994; 330:1629-1633.
4. 4 Caulfield M, Lavender P, Newell-Price J, Farrall M, Kamdar S, Daniel H, el al. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest 1995, 96:687-692.
5. 5 Atwood LD, Kammerer CM, Samollow PB, Hixson JE, Shade RE, MacCluer JW. Linkage of essential hypertension to the angiotensinogen locus in Mexican Americans. Hypertension 1997; 30:326-330.
6. 6 Lesage S, Velho G, Vionnet N, Chatelain N, Demenais F, Passa P, et al. Genetic studies of the renin-angiotensin system in arterial hypertension associated with non-insulin-dependent diabetes mellitus. J Hypertens 1997; 15:601-606.
7. 7 Niu T, Xu X, Rogus J, Zhou Y, Chen C, Yang J, et al. Angiotensinogen gene and hypertension in Chinese. J Clin Invest 1998; 101:188-194.
8. 8 Jeunemaitre X, Charru A, Chatellier G, Dumont C, Sassano P, Soubrier F, et al. M235T variant of the human angiotensinogen gene in unselected hypertensive patients. J Hypertens 1993; 11 (suppl 5):S80-S81.
9. 9 Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K, et al. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994; 93:1285-1287.
10. 10 Iwai N, Shimoike H, Ohmichi N, Kinoshita M. Angiotensinogen gene and blood pressure in the Japanese population. Hypertension 1995; 25:688-693.
11. 11 Johnson AG, Simons LA, Friedlander Y, Simons J, Davis DR, MaCallum J. M235 to T polymorphism of the angiotensinogen gene predicts hypertension in the elderly. J Hypertens 1996; 14:1061-1065.
12. 12 Jeunemaitre X, Inoue I, Williams C, Charru A, Tichet J, Powers M, et al. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 1997; 60:1448-1460.
13. 13 Bloem LJ, Foroud TM, Ambrosius WT, Hanna MP, Tewksbury DA, Pratt JH. Association of the angiotensinogen gene to serum angiotensinogen in blacks and whites. Hypertension 1997; 29:1078-1082.
14. 14 Borecki IB, Province MA, Ludwig EH, Ellison RC, Folsom AR, Heiss G, et al. Associations of candidate loci angiotensinogen and angiotensin-converting enzyme with severe hypertension: the NHLBI family heart study. Ann Epidemiol 1997; 7:13-21.
15. 15 Rotimi C, Cooper R, Ogunbiyi O, Morrison L, Ladipo M, Tewksbury D, et al. Hypertension, serum angiotensinogen, and molecular variants of the angiotensinogen gene among Nigerians. Circulation 1997; 95:2348-2350.
16. 16 Sato N, Katsuya T, Rakugi H, Takami S, Nakata Y, Miki T, et al. Association of variants in critical core promoter element of angiotensinogen gene with increased risk of essential hypertension in Japanese. Hypertension 1997; 30:321-325.
17. 17 Schunkert H, Hense H-W, Gimenez-Roqueplo A, Stieber J, Keil U, Riegger GAJ, et al. The angiotensinogen T235 variant and the use of antihypertensive drugs in a population-based cohort. Hypertension 1997; 29:628-633.
18. 18 Bennett QL, Schrader AP, Morris BJ. Cross-sectional analysis of Met235 to Thr variant of angiotensinogen gene in severe, familial hypertension. Biochem Biophys Res Commun 1993; 197:833-839.
19. 19 Fornage M, Turner ST, Sing CF, Boerwinkle E. Variation at the M235T locus of the angiotensinogen gene and essential hypertension: a population-based case-control study from Rochester, Minnesota. Hum Genet 1995; 96:295-300.
20. 20 Forrester T, McFarlane-Anderson N, Bennet F, Wilks R, Puras A, Cooper R, et al. Angiotensinogen and blood pressure among blacks: findings from a community survey in Jamaica. J Hypertens 1996; 14:315-321.
21. 21 Hingrani AD, Sharma P, Jia H, Hopper R, Brown MJ. Blood pressure and the M235T polymorphism of the angiotensinogen gene. Hypertension 1996; 28:907-911.
22. 22 Kunz R, Kreutz R, Beige J, Distler A, Sharma AM. Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal. Hypertension 1997; 30:1331-1337.
23. 23 Brand E, Chatelain N, Keavney B, Caulfield M, Citterio L, Connell J, et al. Evaluation of the angiotensinogen locus in human essential hypertension: a European study. Hypertension 1998; 31:725-729.
24. 24 Turner ST, Weidman WH, Michels W, Reed TJ, Ormson CL, Fuller T, et al. Distribution of sodium-lithium countertransport and blood pressure in Caucasians five to 89 years of age. Hypertension 1998; 13:378-391.
25. 25 JNC VI. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157:2413-2446.
26. 26 Province MA, Hadley EC, Hornbrook MC, Lipsitz LA, Miller JP, Mulrow CD, et al. Assessing the effects of exercise on falls and injuries in the frail elderly from the FICSIT trials using a pre-planned meta-analysis JAMA 1995; 273:1341-1347.
27. 27 DerSimonian R, Laird N. Meta-analysis in clinical trials. Contr Clin Trials 1986; 7:177-188, 1986.
28. 28 Fornage M, Amos CI, Kardia S, Sing CF, Turner ST, Boerwinkle E. Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males. Circulation 1998; 97:1773-1779.
29. 29 Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, et al. A molecular variant of angiotensinogen associated with preeclampsia. Nature Genet 1993; 4:59-61.
30. 30 SAGE. Statistical Analysis for Genetic Epidemiology, release 3.0. Cleveland, OH: Department of Epidemiology and Biostatistics, Rammelkamp Center for Education and Research, MetroHealth Campus, Case Western Reserve University; 1997.
31. 31 Boerwinkle E, Sing CF The use of measured genotype information in the analysis of quantitative phenotypes in man. III simultaneous estimates of the frequencies and effects of the apolipoprotein E polymorphism and residual polygenic effects on cholesterol, betalipoprotein and triglyceride levels, Am J Hum Genet 1987; 51:211-226.
32. 32 George VT, Elston RC, Testing the association between polymorphic markers and quantitative traits in pedigrees, Genet Epidemiol 1987; 4:193-201.
33. 33 George VT, Elston RC Generalized modulus power transformations. Commun Statist Therory Methods 1988; 17:2933-2952.
34. 34 Kaplan EB, Elston RC A subroutine package for maximum liklihood estimation (MAXLIK): Inst Stat Mimeo Ser 823. Chapel Hill, NC: University of North Carolina; 1972.
35. 35 Cox DR, Cakes D. Analysis of Survival Data. London: Chapman and Hall; 1984.
36. 36 Efron B The jackknife, the bootstrap, and other resampling plans. Philadelphia, PA: SIAM; 1982.